Literature DB >> 17516099

Identification of the porcine homologous of human disease causing trinucleotide repeat sequences.

Lone Bruhn Madsen1, Bo Thomsen, Christina Ane Elisabeth Sølvsten, Christian Bendixen, Merete Fredholm, Arne Lund Jørgensen, Anders Lade Nielsen.   

Abstract

Expansion in the repeat number of intragenic trinucleotide repeats (TNRs) is associated with a variety of inherited human neurodegenerative diseases. To study the composition of TNRs in a mammalian species representing an evolutionary intermediate between humans and rodents, we describe in this paper the identification of porcine noncoding and polyglutamine-encoding TNR regions and the comparison to the homologous TNRs from human, chimpanzee, dog, opossum, rat, and mouse. Several of the porcine TNR regions are highly polymorphic both within and between different breeds. The TNR regions are more conserved in terms of repeat length between humans and pigs than between humans and rodents suggesting that TNR lengths could be implicated in mammalian evolution. The TNRs in the FMR2, SCA6, SCA12, and Huntingtin genes are comparable in length to alleles naturally occurring in humans, and also in FMR1, a long uninterrupted CGG TNR was identified. Most strikingly, we identified a Huntingtin allele with 21 uninterrupted CAG repeats encoding a stretch of 24 polyglutamines. Examination of this particular Huntingtin TNR in 349 porcine offspring showed stable transmission. The presence in the porcine genome of TNRs within genes that, in humans, can undergo pathogenic expansions support the usage of the pig as an alternative animal model for studies of TNR evolution, stability, and functional properties.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17516099     DOI: 10.1007/s10048-007-0088-y

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   3.017


  48 in total

1.  Molecular architecture of CAG repeats in human disease related transcripts.

Authors:  Gracjan Michlewski; Wlodzimierz J Krzyzosiak
Journal:  J Mol Biol       Date:  2004-07-16       Impact factor: 5.469

2.  Antisense transcription and heterochromatin at the DM1 CTG repeats are constrained by CTCF.

Authors:  Diane H Cho; Cortlandt P Thienes; Sarah E Mahoney; Erwin Analau; Galina N Filippova; Stephen J Tapscott
Journal:  Mol Cell       Date:  2005-11-11       Impact factor: 17.970

3.  Expansion of a novel CAG trinucleotide repeat in the 5' region of PPP2R2B is associated with SCA12.

Authors:  S E Holmes; E E O'Hearn; M G McInnis; D A Gorelick-Feldman; J J Kleiderlein; C Callahan; N G Kwak; R G Ingersoll-Ashworth; M Sherr; A J Sumner; A H Sharp; U Ananth; W K Seltzer; M A Boss; A M Vieria-Saecker; J T Epplen; O Riess; C A Ross; R L Margolis
Journal:  Nat Genet       Date:  1999-12       Impact factor: 38.330

4.  Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.

Authors:  J D Brook; M E McCurrach; H G Harley; A J Buckler; D Church; H Aburatani; K Hunter; V P Stanton; J P Thirion; T Hudson
Journal:  Cell       Date:  1992-04-17       Impact factor: 41.582

5.  Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion.

Authors:  G David; N Abbas; G Stevanin; A Dürr; G Yvert; G Cancel; C Weber; G Imbert; F Saudou; E Antoniou; H Drabkin; R Gemmill; P Giunti; A Benomar; N Wood; M Ruberg; Y Agid; J L Mandel; A Brice
Journal:  Nat Genet       Date:  1997-09       Impact factor: 38.330

6.  Comparative genetics of functional trinucleotide tandem repeats in humans and apes.

Authors:  Aida M Andrés; Marta Soldevila; Oscar Lao; Victor Volpini; Naruya Saitou; Howard T Jacobs; Ikuo Hayasaka; Francesc Calafell; Jaume Bertranpetit
Journal:  J Mol Evol       Date:  2004-09       Impact factor: 2.395

7.  Analysis of CAG repeat of the Machado-Joseph gene in human, chimpanzee and monkey populations: a variant nucleotide is associated with the number of CAG repeats.

Authors:  P Limprasert; N Nouri; R A Heyman; C Nopparatana; M Kamonsilp; P L Deininger; B J Keats
Journal:  Hum Mol Genet       Date:  1996-02       Impact factor: 6.150

8.  Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy.

Authors:  H G Harley; J D Brook; S A Rundle; S Crow; W Reardon; A J Buckler; P S Harper; D E Housman; D J Shaw
Journal:  Nature       Date:  1992-02-06       Impact factor: 49.962

9.  Correlation between CTG trinucleotide repeat length and frequency of severe congenital myotonic dystrophy.

Authors:  C Tsilfidis; A E MacKenzie; G Mettler; J Barceló; R G Korneluk
Journal:  Nat Genet       Date:  1992-06       Impact factor: 38.330

10.  Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA).

Authors:  R Koide; T Ikeuchi; O Onodera; H Tanaka; S Igarashi; K Endo; H Takahashi; R Kondo; A Ishikawa; T Hayashi
Journal:  Nat Genet       Date:  1994-01       Impact factor: 38.330

View more
  4 in total

Review 1.  Transgenic pigs as models for translational biomedical research.

Authors:  Bernhard Aigner; Simone Renner; Barbara Kessler; Nikolai Klymiuk; Mayuko Kurome; Annegret Wünsch; Eckhard Wolf
Journal:  J Mol Med (Berl)       Date:  2010-03-26       Impact factor: 4.599

2.  Method used to establish a large animal model of drug-induced acute kidney injury.

Authors:  Si-Yang Wang; Chao-Yang Zhang; Guang-Yan Cai; Xiang-Mei Chen
Journal:  Exp Biol Med (Maywood)       Date:  2021-01-19

3.  Polyglutamine repeats are associated to specific sequence biases that are conserved among eukaryotes.

Authors:  Matteo Ramazzotti; Elodie Monsellier; Choumouss Kamoun; Donatella Degl'Innocenti; Ronald Melki
Journal:  PLoS One       Date:  2012-02-01       Impact factor: 3.240

4.  Bovine proteins containing poly-glutamine repeats are often polymorphic and enriched for components of transcriptional regulatory complexes.

Authors:  Vicki Whan; Matthew Hobbs; Sean McWilliam; David J Lynn; Ylva Strandberg Lutzow; Mehar Khatkar; William Barendse; Herman Raadsma; Ross L Tellam
Journal:  BMC Genomics       Date:  2010-11-23       Impact factor: 3.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.